Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
This study was designed as a non-interventional observational study. Adalimumab was prescribed in the usual manner in accordance with the terms of the local market authorization with regards to dose, population and indication as well as local guidelines.
Age
15–87
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
RA patients treated with adalimumab who satisfied the following conditions:
1. Paid worker (PW) RA patients who are engaged in paid work for more than 35 hours per week
2. Home worker (HW)
* Category 1 unpaid workers; RA patients who are engaged in paid work for less than 35 hours per week
* Category 2 unpaid workers; RA patients who perform basic activities of daily life (household duties, shopping, child caring, exercise, study, etc.) other than PW
You may not be if
1. RA patients showing lowered basic activities of daily life, such as hospitalization and being bedridden
2. RA patients with a history of previous treatment with adalimumab
